Notes from the Field: Pediatric HIV Outbreak in Ratodero, Pakistan — April 2019–April 2020
Weekly / October 22, 2021 / 70(42);1489–1490
Elizabeth M. Rabold, MD1,2; Saqib Ali Shaikh, MSc3; Karl Schenkel, MD4; Mirza Amir Baig, MPH, MHM5; Rana Jawad Asghar, MD6; Ahmed Liban, MPA7; Oliver Morgan, PhD4; Hammad Ali, PhD2 (View author affiliations)
View suggested citationIn April 2019, local media reports alerted the Sindh AIDS Control Program (SACP) in Pakistan of 14 children aged <10 years with new diagnoses of HIV infection in Ratodero, a rural subdistrict of Larkana District in Sindh province* (1). The report of pediatric cases of HIV infection in these children, whose parents all had received negative HIV test results, was concerning given the low number of children living with HIV in Pakistan (4,200 in a population of 79 million children) and the low (<0.1%) HIV prevalence estimate in the general population.†,§ Within 2 weeks, SACP, with assistance from the Pakistan Field Epidemiology and Laboratory Training Program (FELTP), established 18 health care and community testing sites throughout Larkana District to identify additional cases. Testing was limited to specimens from persons who visited these voluntary testing sites, regardless of symptoms, and did not include contact tracing of clients with positive test results for HIV infection or implementation of HIV testing at high-risk clinical entry points (e.g., emergency departments or infectious disease clinics).
By May 18, 2019, among 16,856 persons tested, health officials identified 571 (3.4%) new cases of HIV infection, 463 (81%) of which were in children and adolescents aged ≤15 years, including 355 (62%) aged ≤5 years.¶ In late May 2019, Pakistan’s Federal Health Ministry requested assistance from the World Health Organization (WHO). International partners including other United Nations agencies and CDC joined WHO to support SACP, FELTP, and other local partners in the outbreak investigation and response. Preliminary investigations (including patient interviews, site visits to clinics, hospitals, and blood banks, and review of surveillance data) identified unsafe injection practices at health care facilities, unsafe practices at blood banks, inadequate infection control measures, and improper management of medical waste as possible risk factors. The Expanded Programme on Immunization services in Pakistan, which includes immunizations against hepatitis B, tuberculosis, polio, and other childhood diseases, uses single-use, auto-disable syringes, and thus routine childhood vaccinations were not deemed to be associated with the outbreak. Because most of the children’s mothers were HIV-negative, mother-to-child transmission could not have occurred in most cases. The response team recommended improving infection prevention and control and blood safety, including educating health care workers about safe injection practices, convening task forces with critical stakeholders, and enforcing policy changes and regulations.
After the initial outbreak investigation, dedicated testing sites continued to identify more persons living with HIV. During April 2019–April 2020, a total of 1,353 persons (3.2%) received positive HIV test results in Ratodero. Approximately 75% of newly identified HIV infections occurred in children and adolescents aged <15 years, of which 633 (61%) were boys and 405 (39%) girls.** Consistent with preliminary outbreak investigation findings, a case-control study identified iatrogenic transmission as the predominant mode of HIV transmission, likely related to poor infection prevention and blood safety practices (2). Prevalence of hepatitis B surface antigen (18%) and hepatitis C antibodies (6.5%) among persons with a newly received diagnosis of HIV infection was higher than that in controls (5% and 1%, respectively) and that of the pediatric population in the same province (1.8% and 1.6%, respectively) (3,4). A pending phylogenetic analysis might provide additional information about potential routes of HIV transmission.
Iatrogenic transmission of HIV has been associated with at least four other HIV outbreaks in Pakistan during the past 20 years (5); the high prevalence of hepatitis B and C in the country raises concern for iatrogenic transmission of other bloodborne pathogens. Improvements at the local and national levels in health care practices, community education, and health care provider training with an emphasis on infection prevention and control measures, could help prevent future outbreaks of HIV and other bloodborne infections in Pakistan.
Acknowledgments
Yetmgeta Eyayou Abdella, Serena Brusamento, Fahmida Iqbal Khan, Lisa Hedman, Joumana Hermez, Palitha Gunarathna Mahipala, Muhammed Safdar Pasha, Musa Rahim, Muhammad Tayyab, Lara Vojnov, Walter Zingg, World Health Organization; Fareed Larik, Naveed Masood Memon, Muhammad Asif Syed, Pakistan Field Epidemiology and Laboratory Training Program.
Corresponding author: Elizabeth M. Rabold, nqo6@cdc.gov, 404-498-5703.
1Epidemic Intelligence Service, CDC; 2Division of Global HIV & TB, Center for Global Health, CDC; 3Sindh AIDS Control Programme, Ministry of Health, Karachi, Pakistan; 4World Health Organization, Geneva, Switzerland; 5Pakistan Field Epidemiology and Laboratory Training Program, Islamabad, Pakistan; 6Global Health Strategists & Implementers, Islamabad, Pakistan; 7Division of Global Health Protection, Center for Global Health, CDC.
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Karl Schenkel serves on the scientific advisory board for SORMAS, a surveillance tool from the Helmholtz Centre for Infectious Disease Research, funded by the German government. No other potential conflicts of interest were disclosed.
References
- Mir F, Mahmood F, Siddiqui AR, et al. HIV infection predominantly affecting children in Sindh, Pakistan, 2019: a cross-sectional study of an outbreak. Lancet Infect Dis 2020;20:362–70. https://doi.org/10.1016/S1473-3099(19)30743-1 PMID:31866326
- Mir F, Nathwani AA, Simms V, et al. Factors associated with HIV infection among children in Larkana District, Pakistan: a matched case-control study. Lancet HIV 2021;8:e342–52. https://doi.org/10.1016/S2352-3018(21)00049-7 PMID:34087096
- Ali M, Idrees M, Ali L, et al. Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol J 2011;8:102. https://doi.org/10.1186/1743-422X-8-102 PMID:21375760
- Jafri W, Jafri N, Yakoob J, et al. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 2006;6:101. https://doi.org/10.1186/1471-2334-6-101 PMID:16792819
- Rabold EM, Ali H, Fernandez D, et al. Systematic review of reported HIV outbreaks, Pakistan, 2000–2019. Emerg Infect Dis 2021;27:1039–47. https://doi.org/10.3201/eid2704.204205 PMID:33755545
Suggested citation for this article: Rabold EM, Shaikh SA, Schenkel K, et al. Notes from the Field: Pediatric HIV Outbreak in Ratodero, Pakistan — April 2019–April 2020. MMWR Morb Mortal Wkly Rep 2021;70:1489–1490. DOI: http://dx.doi.org/10.15585/mmwr.mm7042a5.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.